(MD+DI) – Back in April, MD+DI published an article offering five reasons that this would be Zimmer Biomet’s comeback year, and the Warsaw, IN-based company did not let us down. In fact, Zimmer Biomet accomplished even more in 2019 than we could have predicted at that time. […]
(MEDTECHDIVE) – Moody’s sees the U.S. medical device industry as a bright spot in healthcare in the year ahead. In contrast to the positive outlook for devices, the credit ratings agency gave a stable outlook to the global pharmaceuticals and U.S. for-profit hospital industries. […]
Stryker announced today a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical for $30.75 per share, or a total equity value of approximately $4.0 billion and a total enterprise value of approximately $5.4 billion. […]
(HS&M) – Medtronic and Johnson & Johnson remain at the top of the list this year. This was the year of remarkable organic sales growth, and a five-year low for device acquisition activity. The biggest deal of this year was Boston Scientific’s purchase of BTG for $4.2B. […]
(MD+DI) – An industry analyst expects Zimmer Biomet’s Rosa Knee robotic system to represent a formidable competitor to Stryker’s Mako Knee after the Rosa Knee’s full launch later this year. However, both Mako and Rosa have their strengths and weaknesses, and neither is clearly superior, the analyst said. […]
(Financial Times) – When Namal Nawana was wooed to take the top job at Smith & Nephew, he took a hard look at the venerable UK medical devices company and found both a puzzle and an opportunity. […]
Copyright © 2020 | MH Magazine WordPress Theme by MH Themes